Novanta director sells 663 shares at $147.60
A Novanta Inc director disclosed a small planned sale of 663 shares under a Rule 10b5-1 trading plan, leaving him with 662 shares directly held.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Novanta Inc (NOVT) director Thomas N. Secor reported selling 663 shares of common stock on September 11, 2026 at an average price of $147.60 per share in an open market or private transaction. After this sale, he directly holds 662 shares. The transaction was carried out under a pre-established Rule 10b5-1 trading plan adopted on June 12, 2026.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1 | 663 | $147.60 | $98K |
Footnotes (1)
- F1. The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2026.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
pre-established regulatory
open market or private transaction market
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did NOVT report for director Thomas N. Secor?
Was the September 11, 2026 NOVT insider sale made under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.